Page last updated: 2024-10-28

hexamethonium and MODS

hexamethonium has been researched along with MODS in 1 studies

Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ogilvie, RI1

Other Studies

1 other study available for hexamethonium and MODS

ArticleYear
The death of a volunteer research subject: lessons to be learned.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2001, Nov-13, Volume: 165, Issue:10

    Topics: Adult; Clinical Protocols; Fatal Outcome; Female; Ganglionic Blockers; Hexamethonium; Human Experime

2001